1. Home
  2. SNV vs KRYS Comparison

SNV vs KRYS Comparison

Compare SNV & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synovus Financial Corp.

SNV

Synovus Financial Corp.

HOLD

Current Price

$48.44

Market Cap

6.2B

Sector

Finance

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$216.45

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNV
KRYS
Founded
1888
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.3B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
SNV
KRYS
Price
$48.44
$216.45
Analyst Decision
Buy
Strong Buy
Analyst Count
19
9
Target Price
$58.74
$214.22
AVG Volume (30 Days)
900.4K
325.5K
Earning Date
01-14-2026
11-03-2025
Dividend Yield
3.22%
N/A
EPS Growth
143.15
275.72
EPS
5.35
6.66
Revenue
$2,291,796,000.00
$373,164,000.00
Revenue This Year
$30.36
$34.33
Revenue Next Year
$4.80
$48.04
P/E Ratio
$9.06
$32.72
Revenue Growth
31.11
54.51
52 Week Low
$35.94
$122.80
52 Week High
$61.06
$221.84

Technical Indicators

Market Signals
Indicator
SNV
KRYS
Relative Strength Index (RSI) 60.21 70.43
Support Level $43.80 $213.24
Resistance Level $49.46 $221.84
Average True Range (ATR) 1.35 6.84
MACD 0.44 0.66
Stochastic Oscillator 80.91 78.79

Price Performance

Historical Comparison
SNV
KRYS

About SNV Synovus Financial Corp.

Synovus Financial Corp provides commercial and consumer banking in addition to a full suite of specialized products & services such as private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, & international banking to clients through the wholly-owned subsidiary bank, Synovus Bank, and other offices in Alabama, Florida, Georgia, South Carolina, and Tennessee. It has four segments Wholesale Banking, Community Banking, Consumer Banking, and Financial Management Services, out of which the majority is from the Wholesale banking segment.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: